Nova Biomedical is exploring a potential sale that could value it at more than $2 billion, people with knowledge of the matter said.
The privately-held medical device maker is working with advisers to gauge interest from potential buyers, the people said, asking not to be identified discussing confidential information.
Waltham, Massachusetts-based Nova Biomedical has drawn interest from large private equity firms, as well as strategic buyers, according to the people. Deliberations are ongoing and there’s no certainty they’ll result in a deal, they said.
A representative for Nova Biomedical declined to comment.
Nova Biomedical develops and manufactures medical devices and diagnostics equipment that can be used by healthcare providers for advanced blood testing and analysis, according to its website. The company employs more than 1,400 people and has distributors in over 90 countries.
The value of healthcare products deals is up 19% this year to $52 billion, according to data compiled by Bloomberg. The largest transaction in the sector has been Johnson & Johnson’s $13.1 billion purchase of Shockwave Medical Inc., a maker of devices to treat heart disease.
© 2024 Bloomberg L.P.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
